The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
复制标题
DOI：
10.1007/s11481-015-9608-y
复制
发表时间：
2015-06
影响因子：
6.2
通讯作者：
Desprez, Pierre-Yves
中科院分区：
文献类型：
--
作者：
McAllister, Sean D.;Soroceanu, Liliana;Desprez, Pierre-Yves
As a therapeutic agent, most people are familiar with the palliative effects of the primary psychoactive constituent of Cannabis sativa (CS), Δ9-tetrahydrocannabinol (THC), a molecule active at both the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor subtypes. Through the activation primarily of CB1 receptors in the central nervous system, THC can reduce nausea, emesis and pain in cancer patients undergoing chemotherapy. During the last decade, however, several studies have now shown that CB1 and CB2 receptor agonists can act as direct antitumor agents in a variety of aggressive cancers. In addition to THC, there are many other cannabinoids found in CS, and a majority produces little to no psychoactivity due to the inability to activate cannabinoid receptors. For example, the second most abundant cannabinoid in CS is the non-psychoactive cannabidiol (CBD). Using animal models, CBD has been shown to inhibit the progression of many types of cancer including glioblastoma (GBM), breast, lung, prostate and colon cancer. This review will center on mechanisms by which CBD, and other plant-derived cannabinoids inefficient at activating cannabinoid receptors, inhibit tumor cell viability, invasion, metastasis, angiogenesis, and the stem-like potential of cancer stem cells. We will also discuss the ability of non-psychoactive cannabinoids to induce autophagy and apoptotic-mediated cancer cell death, and enhance the activity of first-line agents commonly used in cancer treatment.
登录
查看更多内容
影响因子：
9
作者：
Dando, I.;Donadelli, M.;Costanzo, C.;Pozza, E. Dalla;D'Alessandro, A.;Zolla, L.;Palmieri, M.
通讯作者：
Palmieri, M.
影响因子：
7.3
作者：
De Petrocellis, Luciano;Ligresti, Alessia;Di Marzo, Vincenzo
通讯作者：
Di Marzo, Vincenzo
大麻素通过抑制 Akt 来减少 ErbB2 驱动的乳腺癌进展。
影响因子：
37.3
作者：
Caffarel, Maria M.;Andradas, Clara;Mira, Emilia;Perez-Gomez, Eduardo;Cerutti, Camilla;Moreno-Bueno, Gema;Flores, Juana M.;Garcia-Real, Isabel;Palacios, Jose;Manes, Santos;Guzman, Manuel;Sanchez, Cristina
通讯作者：
Sanchez, Cristina
影响因子：
82.9
作者：
Galve-Roperh, I;Sánchez, C;Guzmán, M
通讯作者：
Guzmán, M
影响因子：
50.3
作者：
Carracedo, A;Lorente, M;Velasco, G
通讯作者：
Velasco, G